+987.9%
MRNA vs ABCL
+138.2%
+849.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ABCL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +0.8% | +12.3% | +12.7% |
| 7D | +20.6% | -10.0% | +30.6% | +26.7% |
| 30D | +27.1% | -10.9% | +38.0% | +34.6% |
| 3M | +353.4% | +101.6% | +251.7% | +256.7% |
| 6M | +446.3% | +167.5% | +278.7% | +289.5% |
| YTD | +776.2% | +259.1% | +517.1% | +450.3% |
| 1Y | +987.9% | +152.2% | +835.8% | +706.4% |
| All | +987.9% | +138.2% | +849.7% | +706.4% |
Cumulative growth
Daily Returns
Daily percentage return beside ABCL.
Daily Out/Under-Performance
Portfolio return minus ABCL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ABCL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ABCL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling